Your browser doesn't support javascript.
loading
Risk factors for the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma according to genetic polymorphisms related to alcohol and nicotine metabolism.
Katada, Chikatoshi; Yokoyama, Tetsuji; Mure, Kanae; Doyama, Hisashi; Nakanishi, Hiroyoshi; Shimizu, Yuichi; Yamamoto, Keiko; Furue, Yasuaki; Tamaoki, Masashi; Koike, Tomoyuki; Kawahara, Yoshiro; Kiyokawa, Hirofumi; Konno, Maki; Yokoyama, Akira; Ohashi, Shinya; Ishikawa, Hideki; Yokoyama, Akira; Muto, Manabu.
Afiliación
  • Katada C; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yokoyama T; Department of Health and Promotion, National Institute of Public Health, Wako, Japan.
  • Mure K; Department of Public Health, Wakayama Medical University School of Medicine, Wakayama, Japan.
  • Doyama H; Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
  • Nakanishi H; Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
  • Shimizu Y; Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan.
  • Yamamoto K; Division of Endoscopy, Hokkaido University Hospital, Sapporo, Japan.
  • Furue Y; Department of Gasroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
  • Tamaoki M; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Koike T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kawahara Y; Department of Practical Gastrointestinal Endoscopy, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
  • Kiyokawa H; Division of Gastroenterology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Konno M; Department of Gastroenterology, Tochigi Cancer Center, Utsunomiya, Japan.
  • Yokoyama A; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ohashi S; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Ishikawa H; Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Yokoyama A; Clinical Research Unit, National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan.
  • Muto M; Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Jpn J Clin Oncol ; 53(9): 774-780, 2023 Aug 30.
Article en En | MEDLINE | ID: mdl-37370215
BACKGROUND: Multiple development of esophageal squamous-cell carcinoma is explained by field cancerization and is associated with alcohol consumption and smoking. We investigated the association between the development of second primary esophageal squamous-cell carcinoma after endoscopic resection for esophageal squamous-cell carcinoma and genetic polymorphisms related to alcohol and nicotine metabolism. METHODS: The study group comprised 56 patients with esophageal squamous-cell carcinoma after endoscopic resection. The main variables were the following: (i) cumulative incidence and total number of second primary esophageal squamous-cell carcinoma according to genetic polymorphisms in alcohol dehydrogenase 1B, aldehyde dehydrogenase 2 and cytochrome P450 2A6; and (ii) risk factors of second primary esophageal squamous-cell carcinoma identified using a multivariate Cox proportional-hazards model. The frequencies of alcohol dehydrogenase 1B, aldehyde dehydrogenase 2 and cytochrome P450 2A6 genetic polymorphisms in the buccal mucosa were analyzed. RESULTS: The median follow-up was 92.8 months (range: 2.7-134.2). Slow-metabolizing alcohol dehydrogenase 1B was associated with a higher 7-year cumulative incidence of second primary esophageal squamous-cell carcinoma (fast-metabolizing alcohol dehydrogenase 1B vs slow-metabolizing alcohol dehydrogenase 1B: 20.5% vs 71.4%, P = 0.006). Slow-metabolizing alcohol dehydrogenase 1B (relative risk [95% confidence interval]: 3.17 [1.49-6.73]), inactive aldehyde dehydrogenase 2 (2.17 [1.01-4.63]) and poorly-metabolizing cytochrome P450 2A6 (4.63 [1.74-12.33]) had a significantly higher total number of second primary esophageal squamous-cell carcinoma per 100 person-years. In the multivariate Cox proportional-hazards model, slow-metabolizing alcohol dehydrogenase 1B was a significant risk factor of the development of second primary esophageal squamous-cell carcinoma (hazard ratio 9.92, 95% confidence interval: 2.35-41.98, P = 0.0018). CONCLUSIONS: Slow-metabolizing alcohol dehydrogenase 1B may be a significant risk factor for the development of second primary esophageal squamous-cell carcinoma. In addition, inactive aldehyde dehydrogenase 2 and poorly-metabolizing cytochrome P450 2A6 may be important factors.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Jpn J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Jpn J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Japón